The global biotechnology reagents market size was valued at USD 34.1 billion in 2023, driven by increasing innovations and funding activities. The market size is anticipated to grow at a CAGR of 8.03% during the forecast period of 2024-2032 to achieve a value of USD 68.4 billion by 2032.
Biotechnology reagents are used in biotechnological procedures to enable certain reactions, analyses, or manipulations within biological systems. These reagents are substances and compounds that play a crucial role in several lab procedures, experiments, and industrial applications associated with biotechnology. They can include a wide range of molecules, compounds, enzymes, buffers, antibodies, nucleic acids, and other materials necessary for tasks such as DNA amplification, protein analysis, cell culture, purification, sequencing, and more.
Biotechnology reagents are extremely useful in research and experiments related to fields such as fields like molecular biology, genetics, biochemistry, pharmaceuticals, and agriculture. Several types of biotechnology reagents can be categorized based on their applications. For instance, molecular biology techniques like PCR (Polymerase Chain Reaction) require reagents such as DNA polymerases, primers, nucleotides, and buffers.
The biotechnology reagents market growth is driven by certain factors such as increased research and development activities. Increasing investments by pharmaceutical companies to research more to find new reagents or explore the full potential of existing reagents. The market is further driven by the increasing interest of market players in stem cell research, and a rise in the number of biotechnology firms. The increasing research activities by pharmaceutical companies to develop new drugs are collectively contributing to market growth. Due to the increased drug development research activities, and number of clinical trials are simultaneously expected to increase and drive market growth in the forecast period.
Latest Launches in the Market to Drive the Biotechnology Reagents Market Demand
The market growth is driven by innovative launches backed by research and investments by the market key players exemplified by the recent launch of a new antibody by Aalto Bio Reagents in May 2023. They have launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B (CM 1431) in response to the escalating cholera outbreak in Africa and southern Asia, as well as a growing risk of a cholera outbreak in the Ukraine . Such developments can result in a brand-new revolution in the market with widespread applications in various fields, propelling the market growth in the forecast period.
Adaptation of Advanced Technologies to Drive the Growth
The market is further expected to be influenced by the increased adoption of advanced technologies. For instance, Biotech companies have started to deploy advanced technologies such as artificial intelligence (AI) to streamline a variety of operational processes via enhanced automation. With the integration of AI in these procedures, the identification of biomarkers that have applications for the development of drugs and diagnostics has become convenient, bolstering global biotechnology reagents market growth.
Research and Studies to Contribute to the Growing Market Size
The market is expected to witness significant growth in the forecast period driven by continuous efforts of key players towards making discoveries associated with market expansion. For instance, the recent innovation of a revolutionary recycling process technology to extract pure polypropylene (PP) from PCR multilayer packaging waste, currently hard to recycle, has been announced by Braskem. Braskem is a leading polyolefins producer in America and a leading producer of biopolymers globally. Braskem also mentioned that they have been awarded funding amounting to USD 600,000. This is a Research, Demonstration, and Development (RD&D) grant from the Reducing Embodied Energy and Decreasing Emissions (REMADE) Institute, a public-private partnership established by the United States Department of Energy (DOE) . Such announcements and funding activities are major factors aiding the biotechnology reagents market size as the procedure performing required activities will eventually require reagents to perform the activity efficiently.
Strategic Collaborations between Key Players to Aid the Market Growth
In May 2023, to continue providing the highest quality laboratory services and state-of-the-art technologies, FlowMetric collaborated directly with Cytek™Biosciences in providing feedback on the pre-designed panels associated with their next generation of flow cytometric instrumentation. Such strategic collaborations are expected to attract researchers and laboratories seeking innovative tools, and individuals preferring high-quality services, further bolstering the global biotechnology reagents market demand.
The Cytek Aurora harnesses full spectrum technology, offering remarkable flexibility and stability. It allows for a diverse range of new fluorochrome combinations without requiring system reconfiguration for each specific application. This system provides high-resolution data at the individual cell level, effectively addressing complex challenges like cells exhibiting high autofluorescence or limited expression of crucial biomarkers, irrespective of the assay's complexity.
Market Breakup by Technology
Market Breakup by Applications
Market Breakup by Region
North America is dominating the global market with increasing activities related to drug development and research dedicated to exploring the full potential of existing reagents, associated with the increasing competition among market players. This may further increase the demand for new reagents with widespread applications and enhanced performance resulting in continuous dominance of North America in the forecast period.
Rising collaborations for better innovations are likely to aid the biotechnology reagents market growth in the coming years. In September 2023, Navigate BioPharma and Becton Dickinson strategically collaborated to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions. Navigate BioPharma, an independently operating subsidiary of Novartis, provides biomarker and bioanalytic solutions for clinical development and CDx applications. The collaboration harnesses Navigate BioPharma's experience in designing and validating biomarker assays with BD’s expertise in flow cytometry and development services.
With this collaboration, the combination of Navigate BioPharma's proficiency in biomarker assays and CDx applications with BD’s specialized knowledge in flow cytometry, and development services is expected to result in a powerful synergy. This may potentially lead to the development of innovative solutions, further bolstering the market growth.
In May 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. Bio-Rad is one of the world's most respected suppliers of blood screening systems, serving blood banks and transfusion centers globally for over 70 years. In an evolving environment, with the IH-500 NEXT System, Bio-Rad offers enhanced benefits to address the current and future needs of laboratories.
The key features of the biotechnology reagents market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Technology
|Breakup by Applications
|Breakup by Region
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biotechnology Reagents Market Overview
3.1 Global Biotechnology Reagents Market Historical Value (2017-2023)
3.2 Global Biotechnology Reagents Market Forecast Value (2024-2032)
4 Global Biotechnology Reagents Market Landscape
4.1 Global Biotechnology Reagents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biotechnology Reagents Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Biotechnology Reagents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biotechnology Reagents Market Segmentation
6.1 Global Biotechnology Reagents Market by Technology
6.1.1 Market Overview
6.1.2 Life Science Reagents
220.127.116.11 Cell Culture
18.104.22.168 In-vitro Diagnostics
22.214.171.124 Other Technologies
6.1.3 Analytical Reagents
126.96.36.199 Mass Spectrometry
188.8.131.52 Flow Cytometry
184.108.40.206 Other Analytical Reagents
6.2 Global Biotechnology Reagents Market by Applications
6.2.1 Market Overview
6.2.2 Protein Synthesis and Purification
6.2.3 Gene Expression
6.2.4 DNA and RNA Analysis
6.2.5 Drug Testing
6.3 Global Biotechnology Reagents Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Biotechnology Reagents Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Biotechnology Reagents Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Biotechnology Reagents Market
9.1 Market Share by Country
10 Latin America Biotechnology Reagents Market
10.1 Market Share by Country
11 Middle East and Africa Biotechnology Reagents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.2 Agilent Technologies Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.6 General Electric
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.7 bioMérieux SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.10 Hoefer, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.11 PerkinElmer Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.12 Merck KGaA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.13 Promega Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.14 Quality Biological
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisition
17.17 TAKARA HOLDINGS INC.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisition
17.18 Sysmex Corporation
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisition
17.19 Tosoh Corporation
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisition
17.20 Olympus Corporation
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisition
18 Global Biotechnology Reagents Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 34.1 billion in 2023, driven by increased innovations.
The market is anticipated to grow at a CAGR of 8.03% during the forecast period of 2024-2032 and is likely to reach a market value of USD 68.4 billion by 2032.
The market growth is further driven by factors such as increased research and development activities, strategic collaborations, adaptation of advanced technologies, increasing interest of market players in stem cell research, and increasing investments are major factors driving the market growth.
The market growth is influenced by new launches by the key players in the market such as the launch of IH-500TM NEXT System by the Rad Laboratories.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Technologies used in biotechnology reagents are life science reagents and analytical reagents.
Biotechnology reagents find wide applications in protein synthesis and purification, gene expression, DNA and RNA analysis, and drug testing, among others.
Key players involved in the market are Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMérieux SA, LONZA, F. Hoffmann-La Roche Ltd., Hoefer, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, and Olympus Corpora.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.